This study explored the mechanism underlying the stimulation of collagen synthesis and osteoblastic differentiation by insulin-like growth factor 1 (IGF1) in primary mouse osteoblasts. Primary mouse calvarial osteoblasts were cultured and treated with various doses of IGF1 before transfection with siRNA targeting the collagen type I alpha 2 (Col1a2) or La ribonucleoprotein domain family member 6 (Larp6) genes. Alkaline phosphatase (ALP) activity, osteocalcin staining, alizarin red quantification and the expression level of runt-related transcription factor 2 (RUNX2) were performed to assess the differentiation of pre-osteoblasts. Based on Western blot analysis, IGF1 up-regulated COL1A2 protein expression in the primary osteoblasts in a dose-and time-dependent manner. In addition, Col1a2 interference inhibited the differentiation and mineralization of osteoblasts. IGF1 also stimulated the differentiation of mouse primary osteoblasts and increased LARP6 expression during osteogenic differentiation. RNA-Immunoprecipitation (IP) indicated that LARP6 could bind to Col1a2 mRNA after IGF1 stimulation. However, transfection of Larp6-specific siRNA significantly reduced collagen and ALP secretion, mineralization and inhibited the expression of osteocalcin and RUNX2, indicating that Larp6 interference inhibited the differentiation ability of primary mouse calvarial osteoblasts, and these effects could not be reversed by IGF1. Thus, IGF1 could promote COL1A2 expression and osteoblast differentiation in primary mouse calvarial preosteoblasts by increasing LARP6 expression via a posttranscriptional mechanism.
Introduction
Fracture healing is a unique repair process in which the events of endochondral and intramembranous bone formation follow a specific time sequence (Loi et al. 2016) . Fracture healing has three major phases: hematoma organization, porosis, and remodeling. In the porosis stage, a large number of osteoblasts differentiate and proliferate along the fibrous tissues formed by the hematoma organization at two fracture ends to form new bone and connect the fracture ends with fresh bone tissue; this is the most important stage in fracture healing (Feron & Mauprivez 2016) . Therefore, osteoblast differentiation and proliferation play a key role in porosis (Claes et al. 2012) . However, the mechanisms underlying osteoblast differentiation and proliferation need to be evaluated.
A growing body of evidence has demonstrated that the bone extracellular matrix (ECM) plays an important role in regulating porosis. The ECM provides structural support, cell migration anchorage, cell differentiation cues, and fine-tuned cell proliferation signals during all stages of bone fracture healing, including cartilaginous callus formation, callus remodeling, and bony bridging of the fracture gap (Evans et al. 2010; Shang et al. 2014) . Collagen type I is a principal component of the ECM. The collagen type I subunit molecule is a fibrilforming heterotrimeric protein composed of two a1 chains and one a2 chain, which fold into a stable and highly ordered triple-helix (Han et al. 2008) . Proper assembly of these subunit molecules is important for the macroscopic fibril structure of collagen and required for its tensile strength, stability, and biological function. Mutations in either of the genes encoding the pro-a1 or pro-a2 chains of type I collagen result in osteogenesis imperfecta, which is characterized by collagen type I synthesis deficiency, and further results in bones that break easily, often from little or no apparent cause (Van Dijk et al. 2010) . Posttranscriptional regulation involves the stabilization of collagen mRNAs and regulation of their translation, and is mediated by two RNA binding proteins: aCP (Lindquist et al. 2004) and La ribonucleoprotein domain family member 6 (LARP6) (Zhang & Stefanovic 2016) .
Previous studies showed that many types of inflammatory cytokines and growth factors, such as interleukin-1 (IL-1), IL-6, tumor necrosis factor-a (TNFa), fibroblast growth factors (FGFs), transforming growth factors (TGFs), bone morphogenetic proteins (BMPs), and insulin-like growth factors (IGFs) are involved in the fracture healing process (Fazzalari 2011) . However, IGF1 is one of the most important factors that stimulate bone formation around bony tissues (Sheng et al. 2014) . A recent study reported that LARP6 is a critical mediator by which IGF1 augments the synthesis of collagen type I in vascular smooth muscle (Blackstock et al. 2014) . We hypothesized that LARP6 also serves as an important mediator by which IGF1 augments the synthesis of collagen type I and osteoblast differentiation.
Materials and methods

Animals and cell culture
The use of these animals was approved by the Animal Ethics Committee of the Central South University. The mice were kept in separate cages, fed with standard diet and maintained under standard animal housing conditions (12 h light, 12 h dark cycles and free access to food and water) in the Laboratory Animal Center of the Second Xiang-Ya Hospital in Central South University. Primary osteoblasts were cultured as described previously (Bakker & Klein-Nulend 2012) . Briefly, healthy newborn C57BL/6J mice (2-3 days old) were killed by cervical dislocation. The craniums were washed with phosphate-buffered saline (PBS) to white and cut into 1 mm 9 l mm 9 1 mm pieces using eye scissors. The pieces were digested with collagenase II at 37°C (digestion repeated four times, 15 min each), the last two out of four digestive cells is enriched with cells exhibiting biochemical characteristics of osteoblasts.
Cells were cultured in a-minimal essential medium (aMEM; Mediatech) containing 10% fetal bovine serum, 100 U/mL penicillin, and 100 lg/mL streptomycin. Experiments were performed at cell passages 2-3 under serum-free conditions with 5% bovine serum albumin, 100 U/mL penicillin, and 100 lg/mL streptomycin. For osteogenic induction, osteoblasts were cultured in serum-free osteogenic medium, which contained 10 mmol/L b-glycerophosphate and 50 lg/mL L-2-ascorbic acid. All cells were cultured at 37°C in an incubator with a humidified atmosphere containing 5% CO 2 and the medium refreshed every 2-3 days.
RNA isolation and quantitative real-time PCR
Total RNA was isolated using Trizol (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. Reverse transcription was performed to generate cDNA from 1 lg total RNA using the PrimeScript RT Reagent Kit, gDNA Eraser (TaKaRa, Otsu, Japan), and random primers. Next, quantitative PCR was performed using primers synthesized by Shanghai Generay Biotech Co., Ltd (Shanghai, China). The primer sequences were as follows: collagen type I alpha 2 (Col1a2) forward, 5
0 -GCCACAGGATTCCATACC CA. Amplification and detection were performed with the SYBR Premix Ex Taq II kit (TaKaRa) and LightCycler Real-time PCR system (Roche). The cycling conditions were: 30 s polymerase activation at 95°C, followed by 40 cycles at 95°C for 5 s and 60°C for 20 s. The melting curves were examined to ensure primer specificity and the data analyzed using the 2 ÀDDCt method.
Protein isolation and Western blot analysis
Both protein isolation and Western blot analysis were performed according to the method described in a previous study (Chan et al. 2011) . Briefly, total protein extracts were prepared in protein lysis solution (150 mmol/L NaCl, 20 mmol/L Tris-HCl pH 7.2, 1 mmol/L ethylenediaminetetraacetic acid (EDTA), 1% Nonidet P-40, 0.5% deoxycholate, 0.1 mmol/L phenylmethylsulfonyl fluoride, 1 mmol/L sodium orthovanadate, 0.1 mokadaic acid, 0.1 lmol/L aprotinin, 10 lg/mL leupeptin, and 10 mmol/L NaF). The concentrations of purified proteins were determined by the bicinchoninic acid protein assay (Pierce, Rockford, IL, USA) using bovine serum albumin (BSA) as the standard protein. Total cell lysates were resolved on 10% wt/vol sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), then transferred to nitrocellulose membrane (Millipore, Billerica, MA, USA).
ª 2017 Japanese Society of Developmental Biologists
The membranes were blocked with 5% non-fat dry milk in TBST (50 mmol/L Tris pH 7.6, 150 mmol/L NaCl, 0.1% Tween 20) and incuated overnight at 4°C in 3% non-fat dry milk in TBST supplemented with primary antibodies against COL1A2 (1:2000; Aviva, CA, USA), LARP6 (1:1000; Thermo Fisher, MA, USA), runt-related transcription factor 2 (RUNX2) (1:1000; Cell Signaling, Danvers, MA, USA) and b-actin (1:1000; Bioss, China). Immunoreactive bands were detected with anti-rabbit peroxidase-conjugated secondary antibody (1:5000; Bioss) and visualized by enhanced chemiluminescence (Amersham Biosciences). The optical density of the bands was analyzed using image analysis software (Image J, NIH, MD, USA).
Alkaline phosphatase staining
Alkaline phosphatase (ALP) analysis was performed as described previously (Wang et al. 2012) . Briefly, the primary osteoblasts were cultured in osteogenic differentiation medium with or without 50 ng/mL IGF1 for 14 days to measure the ALP activity. The cells were fixed with 4% paraformaldehyde for 15 min and ALP staining performed using an ALP assay kit (Sigma) according to the manufacturer's instructions.
Immunohistochemistry
Primary osteoblasts were cultured in osteogenic medium with or without 50 ng/mL IGF1 for 14 days. The cells were fixed with 4% paraformaldehyde for 10 min, permeabilized with 0.05% Triton X-100, and incubated with 1% BSA in PBS for 10 min at room temperature. The coverslips were incubated at 4°C overnight with an osteocalcin polyclonal antibody (1:200, Abcam, USA) and then incubated with secondary antibodies. Antibodies were detected by staining with horseradish peroxidase (HRP)-conjugated rabbit anti-mouse IgG and diaminobenzadine (DAB; GTVision III Detection System/Mo&Rb Kit). The cells were counterstained with hematoxylin and imaged using a microscope (Olympus, Tokyo, Japan).
Alizarin red staining
To detect mineralization, cells were osteogenically induced for 14 days, fixed with 70% ethanol, and stained with 2% alizarin red (Sigma-Aldrich) according to the manufacturer's suggested protocol. The slides were imaged using a microscope (Olympus). 10% cetylpyridinium chloride (CPC) in 10 mmol/L sodium phosphate was added for incubation for 30 min at room temperature. The calcium concentrations were determined according to the absorbance at 562 nm using a standard calcium curve prepared in the same solution and further normalized with the total protein concentrations obtained from the duplicate plates (Fan et al. 2009 ).
Cell transfection
A predesigned small interfering RNA (siRNA) targeting the mouse Col1a2 gene (GenBank accession number NM_12843), mouse Larp6 (GenBank accession number NM_67557), and a negative control siRNA (scrRNA) were purchased from Shanghai GenePharma Co., Ltd (Shanghai, China). The sequence of the Larp6 siRNA was 5 0 -UCCAACUCGUCCACGUCCU-3 0 , which was previously shown to knock down LARP6 protein expression [16] . SiRNA or scrRNA were transfected into primary osteoblasts using Lipofectamine 2000 (Invitrogen) for 6 h. Cells were then placed in serumfree medium for an additional 24 h before treatment with IGF1. To analyze osteogenic differentiation, osteoblasts were cultured in serum-free osteogenesis differentiation medium (10 mmol/L b-glycerophosphate and 50 lg/mL L-2-ascorbic acid) for 8 days and then transfected for 6 h. After transfection, osteoblasts were cultured in serum-free osteogenesis differentiation medium with or without 50 ng/mL IGF1 for an additional 6 days.
RNA-Immunoprecipitation (IP)
Primary osteoblasts were treated with 50 ng/mL IGF1 for 36 h. RNA-IP analyses were performed according to the method described in a previous study (Majumder et al. 2016) . Briefly, cells were collected and lysed in 200 lL of lysis buffer as described above. The total lysate was incubated with RNase-free DNase I (Roche Applied Science) for 20 min. Immunoprecipitated reaction was performed by mixing the extract with anti-LARP6 antibodies (Thermo Fisher) or control mouse non-immune IgG antibodies at 4°C for overnight. Agarose beads (Millipore) were used to pull down the antibody-LARP6-mRNA complexes. The RNAs were extracted from the collected immunoprecipitants using TRIZOL (Invitrogen) and analyzed by GoTaq qPCR Master Mix (Promega, Madison, USA) using primers as described above. The quantitative PCR products were detected by 1.5% agarose gel electrophoresis analyses.
Statistical analysis
Data are expressed as the mean AE standard deviation (SD). Each experiment was repeated at least three times. Differences between groups were analyzed by ª 2017 Japanese Society of Developmental Biologists one-way ANOVA or Student's t-test. P-values <0.05 were considered significant.
Results
IGF1 promoted the differentiation of primary osteoblasts and silencing Col1a2 inhibited osteoblast differentiation
In order to assess the ability of IGF1 to promote primary osteoblast differentiation, primary mouse calvarial osteoblasts were cultured in serum-free osteogenesisinduction medium and exposed to 50 ng/mL IGF1. The expression of ALP, osteocalcin staining, and RUNX2 expression were increased after IGF1 induction for 14 days (Fig. 1 a-c) . Alizarin red staining and quantitative calcium measurements revealed that mineralization was also significantly higher after 50 ng/mL IGF1 induction (Fig. 1 d, e) .
Osteoblasts were cultured in serum-free osteogenesis differentiation medium (10 mmol/L b-glycerophosphate and 50 lg/mL L-2-ascorbic acid) for 8 days Fig. 1 . IGF1 induced osteoblast differentiation and silencing Col1a2 inhibited osteoblast differentiation. Primary mouse calvarial osteoblasts were cultured in serum-free osteogenic differentiation medium with or without 50 ng/mL IGF1 for 14 days followed by staining with ALP and osteocalcin (a). The expression level of RUNX2 was confirmed by Western blot analysis (b) and quantification (c). Mineralization was detected by alizarin red stain (d) and quantitative calcium analysis (e). Treatment with IGF1 (50 ng/mL) significantly increased the expression of osteoblast differentiation markers, such as ALP, osteocalcin, RUNX2 and mineralized nodules. Osteoblasts were cultured in serumfree osteogenesis differentiation medium (10 mmol/L b-glycerophosphate and 50 lg/mL L-2-ascorbic acid) for 8 days and then transfected with siRNA targeting Col1a2 or its negative control (scrRNA) for 6 h, then cultured in serum-free osteogenesis differentiation medium for an 6 days. Col1a2 siRNA inhibited ALP, osteocalcin (f), RUNX2 (g and h) expression and the formation of mineralized nodules (i and j). All error bars represent SD (n = 3). *P < 0.05, **P < 0.01 versus control. Abbreviation: IGF1, insulin-like growth factor 1; Col1a2, collagen type I alpha 2; ALP, alkaline phosphatase, RUNX2, runtrelated transcription factor 2.
ª 2017 Japanese Society of Developmental Biologists and then transfected with siRNA targeting Col1a2 or scrRNA for 6 h, then cultured in serum-free osteogenesis differentiation medium for an additional 6 days. Compared to scrRNA controls, Col1a2-silenced cells had reduced COL1A2 (Online Resource 1) and RUNX2 protein expression (Fig. 1 g, h) . After 6 days of osteogenic induction, ALP, osteocalcin, and mineralized nodules were markedly inhibited in Col1a2-silenced cells compared with cells infected with scrRNA control (Fig. 1 f, i) .
IGF1 promoted collagen secretion by primary osteoblasts in a time-and concentration-dependent manner
To identify potential mechanisms responsible for IGF1 involvement in the fracture healing process, primary mouse calvarial osteoblasts were isolated and treated with IGF1 for 0-48 h (serum-free aMEM medium). IGF1 stimulation for 36 h increased the expression of COL1A2 protein in primary mouse calvarial osteoblasts in a dose-dependent manner (Fig. 2a, c) . Compared to the control group, the trend of COL1A2 expression peaked after stimulation with 50 ng/mL IGF1 for 36 h (Fig. 2c) . However, real-time RT-PCR showed that IGF1 had no significant effect on Col1a2 mRNA expression (Fig. 2b, d ).
IGF1 increased the expression of mRNA-binding protein LARP6
Previous studies have provided evidence that IGF1 can improve the expression of LARP6 in smooth muscle (Blackstock et al. 2014) . Based on these observations, we determined the effects of IGF1 on the expression of LARP6 protein in primary osteoblasts under serum-free conditions. IGF1 stimulation for 36 h increased the expression of LARP6 in a dose-dependent manner, reaching a maximum stimulatory effect at 50 ng/mL (Fig. 3a, b) . LARP6 expression peaked after stimulation with 50 ng/mL IGF1 for 36 h (Fig. 3c,  d) , which was consistent with the results for COL1A2 expression (Fig. 2a, c) . We further detected whether LAPR6 could form ribose nuclear protein (RNP) complexes together with Col1a2 mRNA in primary osteoblasts. Comparing to the control IgG, Col1a2 mRNA was significantly present in the anti-LAPR6 immunoprecipitated complexes (Fig. 3e) . Agarose gel electrophoresis analyses also detected higher qPCR products expression of Col1a2 mRNA (Fig. 3f) .
LARP6 inhibition reduced IGF1-mediated collagen expression
To evaluate whether LARP6 plays a key role in IGF1-induced COL1A2 expression, primary osteoblasts were Fig. 2 . IGF1 dose-and time-dependently increased COL1A2 protein expression. Levels of COL1A2 protein (a), but not Col1a2 mRNA (b), were upregulated by IGF1 stimulation for 36 h in a dosedependent manner. 50 ng/mL IGF1 reached a maxim effect for 36 h and time-dependently increased the levels of COL1A2 protein , IGF-1; , Control (c). but not Col1a2 mRNA , IGF-1; , Control (d). All error bars represent SD (n = 3). **P < 0.01 versus control (serum-free medium, 0 ng/mL IGF1) at specified time point. Abbreviation: IGF1, insulin-like growth factor 1; Col1a2, collagen type I alpha 2.
ª 2017 Japanese Society of Developmental Biologists transfected with Larp6 siRNA or scrRNA control for 6 h. Cells were then placed in serum-free medium for 24 h followed by treatment with IGF1 for an additional 36 h. A nearly undetectable level of LARP6 protein was found in the primary osteoblasts transfected with Larp6 siRNA (Fig. 4a, b) , but it had no effect on the Col1a2 mRNA level (Fig. 4c) . However, the level of COL1A2 protein was decreased by Larp6 siRNA transfection (Fig. 4d) . In contrast to scrRNA transfection in the presence of 50 ng/mL IGF1, 50 ng/mL IGF1 did not significantly enhance COL1A2 protein expression in the siRNA transfection group (Fig. 4d) .
LARP6 inhibition reduced IGF1-mediated primary osteoblast differentiation
Based on the above results, we further explored whether IGF1 promoted the differentiation of primary mouse calvarial osteoblasts through the regulation of LARP6. We induced the differentiation of primary mouse calvarial osteoblasts in serum-free osteogenesis differentiation medium for 8 days and then transfected with siRNA targeting Larp6 or scrRNA for 6 h. After transfection, the osteoblasts were cultured in serumfree osteogenesis differentiation medium with or without 50 ng/mL IGF1 for an additional 6 days. Treatment with 50 ng/mL (IGF1) increased the ALP, osteocalcin, RUNX2 expression level, formation of mineralized nodules and calvarial osteoblasts differentiation on day 14 (Fig. 5) . However, Larp6 siRNA transfection significantly inhibited osteoblast differentiation and decreased the formation of mineralized nodules (Fig. 5c, d ).
Discussion
Fracture healing is a complex process in which several growth factors and specialized cell types from different bone niches respond to restore bone integrity and function (Claes et al. 2012) . IGF1 is likely to be an Fig. 3 . IGF1 increased LARP6 protein expression and induced association of LARP6 with Col1a2 mRNA in primary osteoblasts. IGF1 increased LARP6 protein expression in a dose-dependent manner, reaching the maximum stimulatory effect at 50 ng/mL for 36 h (a, b). 50 ng/mL IGF1 time-dependently increased LARP6 protein levels, which peaked 36 h after stimulation , IGF-1; , Control. (c, d). Primary osteoblasts were treated with IGF1 (50 ng/mL) for 36 h and LARP6 antibody was immunopreciptated from cellular extracts followed RNA extraction. Then the immunoprecipitated RNAs were detected by quantitative (e), normalized to control IgG, or semiquantitative agarose gel electrophoresis using the primers specific for Col1a2 mRNA (f). All error bars represent SD (n = 3). **P < 0.01 versus control (serum-free medium, 0 ng/mL IGF1) at specified time point. ## P < 0.01 versus control (IgG) at specified time point. Abbreviation: IGF1, insulin-like growth factor 1; Larp6, La ribonucleoprotein domain family member 6; Col1a2, collagen type I alpha 2; IP, immunoprecipitation.
ª 2017 Japanese Society of Developmental Biologists important inductor of bone formation, callus healing, and fracture healing in vivo (Zhao et al. 2000; Di Monaco et al. 2009; Granero-Molto et al. 2011; Sheng et al. 2014) . In the present study, IGF1 significantly upregulated the expression of ALP and increased the osteocalcin content and formation of mineralized nodules. Thus, our results indicate that IGF1 promotes osteoblast differentiation and mineralization, which is consistent with previous studies.
The porosis stage of bone fracture healing requires the secretion of a large amount of ECM, including bone collagen (Claes et al. 2012) . Consequently, changes in the amount of type I collagen will lead to delayed porosis. Therefore, the regulation of collagen synthesis has been the focus in fracture healing. COL1A2 is one of the main components of the bone matrix (Lu et al. 2011) ; therefore, we further investigated the influence of different doses of IGF1 on the expression of COL1A2. IGF1 was found to increase collagen secretion in osteoblasts, and collagen type I is a major factor promoting the differentiation of osteoblasts and enhancing the adhesion of osteoblasts, which is the basic guarantee of the maturity and differentiation of osteoblast phenotypes (Rossert et al. 2000) . Moreover, we found that osteoblasts transfected with Col1a2 siRNA had reduced ALP, RUNX2, and mineralized nodule content after osteogenic induction, demonstrating that Col1a2 can regulate osteoblast differentiation. Despite the increased collagen content in osteoblasts treated with IGF1, no significant changes were found in Col1a2 mRNA expression, suggesting that IGF1 regulated collagen expression through a translational but nottranscriptional mechanism.
The biosynthesis of collagen type I involves the translation of individual polypeptides, their posttranslational modification, folding three polypeptides into a triple helix, secretion of the triple helix into the extracellular space, and processing of the secreted procollagen into mature collagen (Kivirikko 1998; Kalson et al. 2013) . The expression of collagen polypeptides is regulated at the transcriptional and posttranscriptional level (Stefanovic et al. 1999; Lindquist et al. 2004; Challa & Stefanovic 2011; Wang & Stefanovic 2014) . Compelling evidence has been presented that posttranscriptional regulation plays an important role in collagen expression (Krupsky et al. 1997; Lindquist et al. 2000; Ricupero et al. 2001; Challa & Stefanovic 2011; Manojlovic & Stefanovic 2012; Stefanovic et al. 2014; Wang & Stefanovic 2014) . Posttranscriptional regulation involves stabilization of collagen mRNAs and regulation of their translation, and is mediated by LARP6 and another RNAbinding protein, aCP (Bayfield et al. 2010; Stefanovic Fig. 4 . Effects of Larp6-specific siRNA transfection on IGF1-induced COL1A2 expression. Primary osteoblasts were transfected with Larp6 siRNA or scrRNA control for 6 h, then were placed in serum-free medium for 24 h followed by treatment with IGF1 for an additional 36 h. LARP6 protein and mRNA expression were significantly reduced after siRNA transfection (a, b). Larp6-specific siRNA transfection abolished the ability of IGF1 to induce COL1A2 protein expression (d), but not Col1a2 mRNA expression , Larp6 siRNA IGF-1 50 ng/mL; , Larp6 siRNA IGF-1 0 ng/mL; , Larp6 scrRNA IGF-1 50 ng/mL; , Larp6 scrRNA IGF-1 0 ng/mL (c). Larp6 scrRNA transfection had no effect on IGF1-induced COL1A2 protein expression (d). All error bars represent SD (n = 3). *P < 0.05 versus control. Abbreviation: IGF1, insulin-like growth factor 1; Larp6, La ribonucleoprotein domain family member 6, Col1a2, collagen type I alpha 2.
ª 2017 Japanese Society of Developmental Biologists 2013; Zhang & Stefanovic 2016) , our study also showed that LARP6 protein can bind to Col1a2 mRNA (Fig. 3e, f) . LARP6 regulates the stability, subcellular localization, and translation of collagen mRNAs by binding a secondary structure found in the 5 0 UTR of collagen a1(I) and a2(I) mRNAs (Wang & Stefanovic 2014; Cai et al. 2010 ). An evolutionarily conserved 5 0 stemloop (5 0 SL) structure is found in the 5 0 UTR of these mRNAs (Cai et al. 2010 ). LARP6 will bind the 5 0 SL with high affinity and specificity and functions as a collagen mRNA specific adapter protein to tether the effectors of translation (Cai et al. 2009 ). Furthermore, Blackstock found that IGF1 upregulates the expression of LARP6 via activation of Akt1 and Akt2 (Blackstock et al. 2014) . Based on these observations, we further examined the effects of IGF1 on LARP6 expression. Osteoblasts treated with IGF1 expressed higher levels of LARP6. Meanwhile LARP6 proteins could form RNP complexes together with Col1a2 mRNA. In contrast, inhibition of Larp6 expression by siRNA significantly reduced IGF1-mediated primary mouse calvarial osteoblast differentiation. These results demonstrated that IGF1 promotes primary mouse calvarial osteoblast differentiation, in part, through the regulation of LARP6 expression. Fig. 5 . Effects of Larp6-specific siRNA transfection on IGF1-induced osteogenic differentiation. Osteoblasts were cultured in serum-free osteogenesis differentiation medium for 8 days and then transfected with siRNA targeting Larp6 or its negative control (scrRNA) for 6 h. After transfection, the osteoblasts were cultured in serum-free osteogenesis differentiation medium with or without 50 ng/mL IGF1 for an additional 6 days followed by staining with ALP, osteocalcin (a). Mineralization was detected by alizarin red stain (b) and quantitative calcium analysis (c). The expression level of RUNX2 was confirmed by Western blot analysis (d). Treatment with IGF1 (50 ng/mL) increased the formation of mineralized matrix nodules and calvarial osteoblast differentiation. However, Larp6 siRNA inhibited ALP and RUNX2 expression and the formation of mineralized nodules. All error bars represent SD (n = 3). **P < 0.01 versus control. Abbreviation: IGF1, insulin-like growth factor 1; Larp6, La ribonucleoprotein domain family member 6; ALP, alkaline phosphatase; RUNX2, runt-related transcription factor 2.
In summary, our study demonstrated that IGF1 promotes osteoblast differentiation by increasing the secretion of extracellular matrix and inducing LARP6 expression. LARP6 regulates Col1a2 expression via posttranscriptional modification. Thus, our experimental studies shed new light on the mechanisms underlying IGF1-induced osteogenic differentiation and COL1A2 synthesis.
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